The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Moran, Gary P
Sullivan, Derek J
AffiliationDepartment of Microbiology and Virology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia. firstname.lastname@example.org
Drug Resistance, Fungal
Gene Expression Regulation, Fungal
Microbial Sensitivity Tests
MetadataShow full item record
CitationThe expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole. 2009, 52 (2):118-28 Mycoses
AbstractThe expression of the ERG1, ERG3, ERG7, ERG9, ERG11 and ERG25 genes in response to incubation with fluconazole and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates. The viability of biofilm was measured using an 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction assay and confocal scanning laser microscopy (CSLM). Expression of the ERG11 gene was found to be low or moderate and it was regulated by fluconazole addition more so than by biofilm formation. Very low or non-detectable expression of ERG1, ERG7 and ERG25 genes was detected in C. albicans. The expression of the ERG9 increased in the presence of fluconazole in some isolates. Following incubation with fluconazole, formation of biofilm by C. dubliniensis was coupled with up-regulation of the ERG3 and ERG25 genes as have been observed previously in C. albicans. Planktonic cells of both Candida species released from biofilm displayed similar resistance mechanisms to fluconazole like attached cells. The XTT reduction assay and CSLM revealed that although incubation with fluconazole decreased the biofilm thickness, these were still comprised metabolically active cells able to disseminate and produce biofilm. Our data indicate that biofilm represents a highly adapted community reflecting the individuality of clinical isolates.
- Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms.
- Authors: Nailis H, Vandenbosch D, Deforce D, Nelis HJ, Coenye T
- Issue date: 2010 May
- Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.
- Authors: Yu LH, Wei X, Ma M, Chen XJ, Xu SB
- Issue date: 2012 Feb
- In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
- Authors: De Logu A, Saddi M, Cardia MC, Borgna R, Sanna C, Saddi B, Maccioni E
- Issue date: 2005 May
- Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
- Authors: Bruzual I, Riggle P, Hadley S, Kumamoto CA
- Issue date: 2007 Mar
- Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals.
- Authors: Watamoto T, Samaranayake LP, Egusa H, Yatani H, Seneviratne CJ
- Issue date: 2011 Sep